Evommune, Inc. (EVMN) Operating income 2024–2025
Evommune, Inc. (EVMN) annual operating income history from SEC filings — each fiscal year as reported.
-$81.1MFY2025 · since FY2024: -$70.0M → -$81.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$81.1M | -15.8% |
| FY2024 | -$70.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice